These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 24457075)
1. Optimal protocol for PTEN immunostaining; role of analytical and preanalytical variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues. Maiques O; Santacana M; Valls J; Pallares J; Mirantes C; Gatius S; García Dios DA; Amant F; Pedersen HC; Dolcet X; Matias-Guiu X Hum Pathol; 2014 Mar; 45(3):522-32. PubMed ID: 24457075 [TBL] [Abstract][Full Text] [Related]
2. Effect of Preanalytic Variables on an Automated PTEN Immunohistochemistry Assay for Prostate Cancer. Guedes LB; Morais CL; Fedor H; Hicks J; Gurel B; Melamed J; Lee P; Gopalan A; Knudsen BS; True LD; Scher HI; Fine SW; Trock BJ; De Marzo AM; Lotan TL Arch Pathol Lab Med; 2019 Mar; 143(3):338-348. PubMed ID: 30295067 [TBL] [Abstract][Full Text] [Related]
3. Immunoexpression of Cyclin D1 and PTEN in Various Endometrial Pathologies. Shawana S; Kehar SI; Masood S; Aamir I J Coll Physicians Surg Pak; 2016 Apr; 26(4):277-82. PubMed ID: 27097697 [TBL] [Abstract][Full Text] [Related]
4. Correlation between NDRG1 and PTEN expression in endometrial carcinoma. Chen J; Li S; Yang Z; Lu G; Hu H Cancer Sci; 2008 Apr; 99(4):706-10. PubMed ID: 18377423 [TBL] [Abstract][Full Text] [Related]
5. Pathologic scoring of PTEN immunohistochemistry in endometrial carcinoma is highly reproducible. Garg K; Broaddus RR; Soslow RA; Urbauer DL; Levine DA; Djordjevic B Int J Gynecol Pathol; 2012 Jan; 31(1):48-56. PubMed ID: 22123723 [TBL] [Abstract][Full Text] [Related]
6. A robust immunohistochemical assay for detecting PTEN expression in human tumors. Sangale Z; Prass C; Carlson A; Tikishvili E; Degrado J; Lanchbury J; Stone S Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):173-83. PubMed ID: 20930614 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical assessment of PTEN in vulvar cancer: best practices for tissue staining, evaluation, and clinical association. Lavorato-Rocha AM; Anjos LG; Cunha IW; Vassallo J; Soares FA; Rocha RM Methods; 2015 May; 77-78():20-4. PubMed ID: 25562748 [TBL] [Abstract][Full Text] [Related]
8. Best practice for PTEN gene and protein assessment in anatomic pathology. Carvalho KC; Maia BM; Omae SV; Rocha AA; Covizzi LP; Vassallo J; Rocha RM; Soares FA Acta Histochem; 2014 Jan; 116(1):25-31. PubMed ID: 23746542 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities. Pallares J; Bussaglia E; Martínez-Guitarte JL; Dolcet X; Llobet D; Rue M; Sanchez-Verde L; Palacios J; Prat J; Matias-Guiu X Mod Pathol; 2005 May; 18(5):719-27. PubMed ID: 15578076 [TBL] [Abstract][Full Text] [Related]
10. Expression of phosphatase and tensin homologue in imprint smears of endometrial carcinoma. Kosmas K; Mitropoulou G; Provatas I; Stamoulas M; Marouga A Cytopathology; 2018 Dec; 29(6):558-564. PubMed ID: 30007089 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of PTEN and beta-catenin for endometrial intraepithelial neoplasia in Japanese women. Norimatsu Y; Moriya T; Kobayashi TK; Sakurai T; Shimizu K; Tsukayama C; Ohno E Ann Diagn Pathol; 2007 Apr; 11(2):103-8. PubMed ID: 17349568 [TBL] [Abstract][Full Text] [Related]
12. Loss of PTEN Expression Detected by Fluorescence Immunohistochemistry Predicts Lethal Prostate Cancer in Men Treated with Prostatectomy. Hamid AA; Gray KP; Huang Y; Bowden M; Pomerantz M; Loda M; Sweeney CJ Eur Urol Oncol; 2019 Sep; 2(5):475-482. PubMed ID: 31411988 [TBL] [Abstract][Full Text] [Related]
13. Detection of PTEN immunoreactivity in endometrial hyperplasia and adenocarcinoma. Tantbirojn P; Triratanachat S; Trivijitsilp P; Niruthisard S J Med Assoc Thai; 2008 Aug; 91(8):1161-5. PubMed ID: 18788685 [TBL] [Abstract][Full Text] [Related]
14. Expressions and significances of TTF-1 and PTEN in early endometrial cancer. Zhang HM; Fan TT; Li W; Li XX Eur Rev Med Pharmacol Sci; 2017 Jul; 21(3 Suppl):20-26. PubMed ID: 28745797 [TBL] [Abstract][Full Text] [Related]
15. PTEN mRNA detection by chromogenic, RNA in situ technologies: a reliable alternative to PTEN immunohistochemistry. Bingham V; Ong CW; James J; Maxwell P; Waugh D; Salto-Tellez M; McQuaid S Hum Pathol; 2016 Jan; 47(1):95-103. PubMed ID: 26518664 [TBL] [Abstract][Full Text] [Related]
16. The immunohistochemical profile of atypical eosinophilic syncytial changes vs serous carcinoma. Haley SL; Malhotra RK; Qiu S; Eltorky ME Ann Diagn Pathol; 2011 Dec; 15(6):402-6. PubMed ID: 21855381 [TBL] [Abstract][Full Text] [Related]
17. Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium. Erkanli S; Kayaselcuk F; Kuscu E; Bagis T; Bolat F; Haberal A; Demirhan B Int J Gynecol Cancer; 2006; 16(3):1412-8. PubMed ID: 16803539 [TBL] [Abstract][Full Text] [Related]
18. Expression of PTEN in endometrial liquid-based cytology. Di Lorito A; Zappacosta R; Capanna S; Gatta DM; Rosini S; Schmitt FC Acta Cytol; 2014; 58(5):495-500. PubMed ID: 25358681 [TBL] [Abstract][Full Text] [Related]
19. Immunoexpression of the PTEN protein and matrix metalloproteinase-2 in endometrial cysts, endometrioid and clear cell ovarian cancer. Brucka A; Szyłło K Ginekol Pol; 2013 May; 84(5):344-51. PubMed ID: 23819399 [TBL] [Abstract][Full Text] [Related]
20. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma. Xiong Y; Xiong YY; Zhou YF Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]